{"id":71415,"date":"2026-05-20T09:31:24","date_gmt":"2026-05-20T09:31:24","guid":{"rendered":"https:\/\/medsbase.com\/super-shred\/"},"modified":"2026-05-24T13:34:15","modified_gmt":"2026-05-24T13:34:15","slug":"super-shred","status":"publish","type":"product","link":"https:\/\/medsbase.com\/de\/product\/super-shred\/","title":{"rendered":"Super Shred (L-Carnitin + MIC + ATP + Albuterol + B12 Compound-Mischung)"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Kurze Antwort \u2014 Was ist Super Shred?<\/h3>\n<p style=\"margin: 0;\"><strong>Super Shred<\/strong> is a multi-ingredient compounded studies-injectable blend supplied as a sterile liquid solution at 553 mg\/mL total active concentration in 10 mL vials. Each vial combines five distinct mitochondrial \/ lipotropic \/ \u03b22-adrenergic \/ cofactor compounds in one pre-formulated solution: L-carnitine (mitochondrial fatty-acid shuttle), MIC blend (methionine + inositol + choline lipotropics), ATP (cellular energy substrate), albuterol (\u03b22-adrenergic agonist), and vitamin B12 (cyanocobalamin cofactor). Designed for fat-oxidation, mitochondrial-function, and adrenergic-metabolic support protocols where multi-axis intervention is the study goal. <strong>Kein Peptid<\/strong> \u2014 a small-molecule compounded blend. Supplied ready for use.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Was Sie bei MedsBase erhalten:<\/strong> Sterile pre-formulated liquid studies blend \u00b7 HPLC-verified component purity (COA on request) \u00b7 Discreet temperature-controlled packaging \u00b7 Worldwide peptide courier \u00b7 1,400+ verified <a href=\"https:\/\/medsbase.com\/de\/reviews\/\">Kundenbewertungen<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Jede Bestellung ist durch unsere <a href=\"https:\/\/medsbase.com\/de\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> abgedeckt \u2014 wenn Ihr Paket nicht innerhalb von 20 Werktagen ankommt, versenden wir es erneut.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Spezifikation<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Produkttyp<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Multi-ingredient compounded studies-injectable blend (5 active components); <em>kein Peptid<\/em>; vorgefertigte sterile Fl\u00fcssigl\u00f6sung<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Gesamtkonzentration der Wirkstoffe<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">553 mg\/mL (Summe aller f\u00fcnf Komponenten)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Flaschenvolumen<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">10 mL (multi-dose vial)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Gesamtwirkstoffmasse pro Flasche<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">5.530 mg kombinierte Wirkstoffe pro 10-mL-Flasche<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS-Nummer<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Mehrkomponentenprodukt \u2014 siehe Wirkstofftabelle unten f\u00fcr individuelle CAS-Nummern<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequenz<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">n\/a (Mehrkomponenten-Blend aus kleinen Molek\u00fclen \u2014 kein Peptid)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Molekularformel<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Kombinierter Mehrfachwirkstoff-Blend \u2014 L-Carnitin (C<sub>7<\/sub>H<sub>15<\/sub>NEIN<sub>3<\/sub>) + Methionin + Inositol + Cholin (MIC) + ATP (C<sub>10<\/sub>H<sub>16<\/sub>N<sub>5<\/sub>O<sub>13<\/sub>P<sub>3<\/sub>) + Albuterol (C<sub>13<\/sub>H<sub>21<\/sub>NEIN<sub>3<\/sub>) + Vitamin B12 (C<sub>63<\/sub>H<sub>88<\/sub>CoN<sub>14<\/sub>O<sub>14<\/sub>P). Keine einzelne Molek\u00fclformel aufgrund der Blendezusammensetzung.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Form<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Sterile w\u00e4ssrige Fl\u00fcssigl\u00f6sung, gebrauchsfertig (keine Rekonstitution erforderlich); klare, blassgelbe Erscheinung (B12-F\u00e4rbung dominant)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Komponentenreinheit<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Alle Komponenten \u226599% (HPLC-verifiziert einzeln; Mischungs-COA auf Anfrage)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Lagerung<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bei 2\u20138 \u00b0C k\u00fchlen, sofort nach Erhalt. <strong>Nicht einfrieren<\/strong> \u2014 Gefrier-Auftau-Zyklen k\u00f6nnen B12-Abbau und ATP-Hydrolyse verursachen. Lichtgesch\u00fctzt lagern (B12 ist lichtempfindlich). Innerhalb von 60 Tagen nach erstem \u00d6ffnen der Flasche verwenden. Sterile Mehrdosisflasche \u2014 aseptische Entnahmetechnik anwenden.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Rekonstitution<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Nicht erforderlich \u2014 vorkonfigurierte sterile Fl\u00fcssigkeit. Vor jeder Entnahme leicht schwenken, um gleichm\u00e4\u00dfige Durchmischung der f\u00fcnf Komponenten zu gew\u00e4hrleisten.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Zusammensetzung \u2014 Pro mL und pro 10-mL-Flasche<\/h2>\n<p>Jede 10-mL-Super-Shred-Flasche enth\u00e4lt folgende f\u00fcnf Wirkstoffe in steriler w\u00e4ssriger L\u00f6sung. CAS-Nummer, Summenformel, Molekulargewicht und Mengen pro mL\/pro Flasche sind unten zur Spezifikationsreferenz aufgef\u00fchrt. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left;\">Komponente<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">CAS<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Mol. Formel<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">MW (Da)<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">mg\/mL<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">mg\/Flasche<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>L-Carnitin<\/strong> (Levocarnitin)<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">541-15-1<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>7<\/sub>H<sub>15<\/sub>NEIN<sub>3<\/sub><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">161.20<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">400<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">4,000<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>MIC-Blend<\/strong> \u2014 Methionin + Inositol + Cholin<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">63-68-3 \/ 87-89-8 \/ 67-48-1<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>5<\/sub>H<sub>11<\/sub>NEIN<sub>2<\/sub>S\/C<sub>6<\/sub>H<sub>12<\/sub>O<sub>6<\/sub> \/ C<sub>5<\/sub>H<sub>14<\/sub>ClNO<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">149.21 \/ 180.16 \/ 139.62<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">100 (kombiniert)<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">1.000 (kombiniert)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>ATP<\/strong> (Adenosintriphosphat Dinatriumsalz)<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">987-65-5<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>10<\/sub>H<sub>14<\/sub>N<sub>5<\/sub>Na<sub>2<\/sub>O<sub>13<\/sub>P<sub>3<\/sub><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">551.14<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">50<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">500<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Albuterol<\/strong> (Salbutamol; \u03b22-Adrenergikum)<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">18559-94-9<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>13<\/sub>H<sub>21<\/sub>NEIN<sub>3<\/sub><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">239.31<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">2<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">20<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Vitamin B12<\/strong> (Cyanocobalamin)<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">68-19-9<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>63<\/sub>H<sub>88<\/sub>CoN<sub>14<\/sub>O<sub>14<\/sub>P<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">1,355.4<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">1<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">10<\/td>\n<\/tr>\n<tr style=\"background: #eef7ee;\">\n<td style=\"padding: 8px 12px; border-bottom: 2px solid #4caf50;\"><strong>GESAMT<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 2px solid #4caf50;\">\u2014<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 2px solid #4caf50;\">\u2014<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 2px solid #4caf50;\">\u2014<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 2px solid #4caf50;\"><strong>553 mg\/mL<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 2px solid #4caf50;\"><strong>5.530 mg\/Vial<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Was ist die Super Shred Blend?<\/h2>\n<p><strong>Super Shred<\/strong> is a pharmaceutical-grade compounded liquid blend that combines five complementary metabolic and adrenergic compounds in a single pre-formulated sterile injectable solution. The blend is engineered to recruit several distinct mechanisms relevant to fat-oxidation, mitochondrial-function, and adrenergic-metabolic support in one administration: substrate-side support for mitochondrial fatty-acid transport (L-carnitine), hepatic lipid-export support (MIC lipotropic axis), cellular energy-currency support (ATP), \u03b22-adrenergic-receptor agonism (albuterol), and one-carbon-cycle cofactor support (B12). Unlike the lyophilized peptide products in this catalogue, Super Shred is supplied as a ready-to-use sterile liquid at 553 mg\/mL total active concentration \u2014 no reconstitution required. Each of the five components has a distinct studies profile, well-documented mechanism, and substantial published literature in its own right. The compounded blend format is offered because many protocols that examine multi-axis metabolic intervention (substrate availability \u00d7 electron-transport \u00d7 adrenergic stimulation) require simultaneous administration of all five compounds at fixed ratios \u2014 making pre-formulated co-administration substantially more practical than reconstituting and combining each component separately for each dosing event. Super Shred contains <strong>Albuterol<\/strong> (salbutamol), a regulated \u03b22-adrenergic agonist with established clinical use in respiratory medicine. Users ordering this product are responsible for compliance with the regulatory framework that applies in their jurisdiction. The blend is <strong>nicht zugelassen<\/strong> by the FDA, EMA, MHRA, or any other major regulator as a compounded formulation, and individual components have varying approval status (levocarnitine and cyanocobalamin are FDA-approved; albuterol is FDA-approved by inhalation and oral route but not as part of this blend; ATP and MIC components are not approved). <\/p>\n<h2>Wirkmechanismus \u2013 F\u00fcnf komplement\u00e4re Wege<\/h2>\n<p>The five components in Super Shred recruit complementary studies-relevant mechanisms:<\/p>\n<ul>\n<li><strong>L-Carnitin \u2013 Mitochondrialer Langkettig-Fetts\u00e4ure-Shuttle.<\/strong> Levocarnitin ist der obligate Tr\u00e4ger f\u00fcr langkettige Fetts\u00e4uren \u00fcber die ansonsten undurchl\u00e4ssige mitochondriale Innenmembran via des CPT-I \/ CACT \/ CPT-II Transportsystems. Bei 400 mg\/mL dominiert die L-Carnitin-Dosis der Mischung die Gesamtmasse; das Designziel ist es, substratseitiges Substrat bereitzustellen, damit die \u03b2-Oxidation nicht durch die Tr\u00e4gerverf\u00fcgbarkeit begrenzt wird. Siehe <a href=\"https:\/\/medsbase.com\/de\/l-carnitine\/\">eigenst\u00e4ndiges L-Carnitin<\/a> f\u00fcr vollst\u00e4ndige mechanistische Details.<\/li>\n<li><strong>MIC-Blend (Methionin, Inositol, Cholin) \u2013 Hepatischer Lipidexport und Methylgruppen-Donor-Unterst\u00fctzung.<\/strong> The classical &#8220;MIC lipotropic&#8221; mixture in dosing supports hepatic phosphatidylcholine biosynthesis (via choline), one-carbon metabolism and S-adenosylmethionine pool (via methionine), and inositol-phospholipid signalling (via myo-inositol). Together these support the hepatic export of triglyceride-rich very-low-density lipoprotein (VLDL), which is the downstream limiting step for liver fat clearance. The 100 mg\/mL combined dose places MIC in a moderate-supplementation range used in published studies protocols on hepatic steatosis and fat-mobilisation models.<\/li>\n<li><strong>ATP (Adenosintriphosphat-Dinatriumsalz) \u2014 Energiew\u00e4hrung der Zelle.<\/strong> Exogenous ATP has been studied in cardiovascular, ischemia-reperfusion, and exercise-physiology contexts. While intracellular ATP is rapidly synthesised by mitochondria and cannot be directly imported from the extracellular space, extracellular ATP signals through purinergic receptors (P2X \/ P2Y families) and contributes to vasodilation, mast-cell modulation, and endothelial signalling. ATP also serves as a substrate reserve for circulating adenosine generation by ectonucleotidases (CD39 \/ CD73).<\/li>\n<li><strong>Albuterol (Salbutamol) \u2014 \u03b22-adrenerger Rezeptoragonist.<\/strong> Albuterol is a short-acting selective \u03b22-adrenergic receptor agonist. At the molecular level it activates G\u03b1s-coupled \u03b22-receptors on multiple tissues \u2014 including bronchial smooth muscle (the indication for which it is clinically approved), but also skeletal muscle (where it promotes glycogenolysis, lipolysis, and protein synthesis at supraphysiological doses), adipose tissue (lipolysis via cAMP \/ hormone-sensitive lipase), and the central nervous system (CNS-stimulant-like effects). Albuterol is on the WADA Prohibited List above defined urinary thresholds. Users handling albuterol must be aware of local regulatory status \u2014 albuterol is a regulated drug in most jurisdictions and is a controlled substance in some athletic-regulatory frameworks.<\/li>\n<li><strong>Vitamin B12 (Cyanocobalamin) \u2014 Cofaktor des Ein-Kohlenstoff-Zyklus.<\/strong> B12 ist ein essenzieller Cofaktor f\u00fcr Methionin-Synthase und Methylmalonyl-CoA-Mutase und unterst\u00fctzt den Ein-Kohlenstoff-Stoffwechsel, die S-Adenosylmethionin (SAM)-Synthese und den Abbau von Fetts\u00e4uren mit ungerader Kohlenstoffzahl. Ein B12-Mangel st\u00f6rt Methylierungsreaktionen, neurologische Funktionen und die Erythropoese. In zusammengesetzten lipotropen Mischungen wird B12 sowohl als Cofaktor des Ein-Kohlenstoff-Zyklus (synergistisch mit MIC) als auch als sichtbarer Qualit\u00e4tskontrollmarker verwendet \u2014 seine rote Pigmentierung signalisiert, dass die Mischung intakt ist.<\/li>\n<\/ul>\n<p>The combined blend acts on substrate availability (L-carnitine), hepatic processing (MIC), cellular energy (ATP), adrenergic-receptor stimulation (albuterol), and methyl-cofactor support (B12) simultaneously. Study protocols that aim to dissect multi-axis interventions in fat-oxidation or metabolic-flexibility models use compounded co-administration of the full blend; users needing to dissect single-axis contributions instead use the standalone components separately (see <a href=\"https:\/\/medsbase.com\/de\/l-carnitine\/\">L-Carnitin einzeln<\/a>, <a href=\"https:\/\/medsbase.com\/de\/nad\/\">NAD\u207a<\/a>). <\/p>\n<h2>Published Evidence<\/h2>\n<p>Super Shred is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Multi-axis fat-oxidation studies<\/strong> \u2014 combined substrate-availability + adrenergic-stimulation + hepatic-export studies in rodent and large-animal models<\/li>\n<li><strong>Adrenergic-metabolic interaction studies<\/strong> \u2014 \u03b22-adrenerge Stimulation der Skelettmuskel-Lipolyse in Gegenwart von mitochondrialem Substrat (L-Carnitin) und Methyl-Donor-Cofaktoren<\/li>\n<li><strong>Bewegungsphysiologie und Substratverwertung<\/strong> \u2014 multikomponente Interventionsstudien zu Ausdauerleistung, Substratwechsel und post-exercise recovery in Nagetier- und Gro\u00dftiermodellen (sofern lokale regulatorische Rahmenbedingungen dies zulassen)<\/li>\n<li><strong>Hepatic lipid-clearance studies<\/strong> \u2014 the MIC component is the classical lipotropic studies mixture for hepatic-steatosis and VLDL-export models<\/li>\n<li><strong>Mitochondrial-bioenergetic studies<\/strong> \u2014 combined substrate + cofactor intervention on mitochondrial function in cardiac, hepatic, and skeletal-muscle studies<\/li>\n<li><strong>Purinergic signalling studies<\/strong> \u2014 the ATP component supports extracellular purinergic receptor studies alongside the other metabolic compounds<\/li>\n<li><strong>Compounded-blend formulation studies<\/strong> \u2014 studies on the stability, pharmacokinetic interactions, and bioavailability of multi-ingredient liquid studies blends<\/li>\n<\/ul>\n<p>For broader context on related single-component mitochondrial \/ metabolic support compounds in this catalogue, see <a href=\"https:\/\/medsbase.com\/de\/l-carnitine\/\">L-Carnitin einzeln<\/a> (mitochondrialer Fetts\u00e4ure-Shuttle), <a href=\"https:\/\/medsbase.com\/de\/nad\/\">NAD\u207a<\/a> (Elektronentransport-Coenzym), <a href=\"https:\/\/medsbase.com\/de\/ss-31-elamipretide\/\">SS-31 (Elamipretide)<\/a> (Cardiolipin-gerichtetes mitochondriales Peptid), und <a href=\"https:\/\/medsbase.com\/de\/mots-c\/\">MOTS-c<\/a> (mitochondrial abgeleitetes metabolisches Regulatorpeptid). Durchsuchen Sie das vollst\u00e4ndige <a href=\"https:\/\/medsbase.com\/de\/peptides\/\">peptides &amp; compounds catalog<\/a> f\u00fcr verwandte Verbindungen. <\/p>\n<h2>Verf\u00fcgbare Packungsgr\u00f6\u00dfen<\/h2>\n<p>MedsBase stocks Super Shred in three pack sizes calibrated to typical protocol durations. Each pack contains 10 mL vials of pre-formulated 553 mg\/mL solution:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Packungsgr\u00f6\u00dfe<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Gesamtfl\u00fcssigkeit<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Gesamtaktivmasse<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Typische <\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>1 Fl\u00e4schchen<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 mL<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">5.530 mg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pilotstudien mit Einzelkohorte, Kurzzyklus-Protokolle, Dosistitration<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 Fl\u00e4schchen<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">50 mL<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">27.650 mg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 multi-week protocols, multi-cohort studies, ladder discount applied<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 Fl\u00e4schchen<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">100 mL<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">55.300 mg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Erweiterte Zyklen-\/Gro\u00dfkohorten-Protokolle, maximaler Staffelrabatt<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Vergleich \u2014 Super Shred vs. reines L-Carnitin<\/h2>\n<p>Super Shred und <a href=\"https:\/\/medsbase.com\/de\/l-carnitine\/\">eigenst\u00e4ndiges L-Carnitin<\/a> share L-carnitine as a major component but differ substantially in formulation strategy, complexity, and use case. Standalone L-Carnitine is a single-axis tool for substrate-side mitochondrial fat-oxidation studies. Super Shred is a multi-axis compounded blend designed for protocols that require simultaneous substrate, adrenergic, and cofactor intervention. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Kriterium<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Super Shred<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">L-Carnitin einzeln<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Komponenten<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">5 (L-Carnitin, MIC, ATP, Albuterol, B12)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1 (L-Carnitin)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Form<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Vorgefertigte sterile Fl\u00fcssigkeit (keine Rekonstitution erforderlich)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Lyophilisat (Rekonstitution erforderlich)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Studies design<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Mehrdimensionale Intervention; Substrat \u00d7 adrenerg \u00d7 Cofaktor gleichzeitig<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Single-axis substrate-availability studies<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Mechanistische Aufschl\u00fcsselung<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Verbundeffekte k\u00f6nnen nicht eindeutig einem einzelnen Mechanismus zugeordnet werden<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Effekte, die spezifisch auf die Substrat-seitige Intervention zur\u00fcckzuf\u00fchren sind<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Regulatorische Komplexit\u00e4t<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">H\u00f6her \u2014 enth\u00e4lt Albuterol (Rx + WADA-gelistet)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Niedriger \u2014 FDA-zugelassenes einzelnes kleines Molek\u00fcl<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Lagerung<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">K\u00fchlen (nicht einfrieren); 60 Tage nach dem Anstechen<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">K\u00fchlen oder einfrieren (lyophilisiert); 30 Tage nach der Rekonstitution<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Best-fit studies scenario<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Multi-axis applied studies, exercise-physiology, fat-oxidation panel work<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Einzelmechanismus-Studien, mitochondriale Bioenergetik-Dissektion<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For mechanistic single-component studies where a clean attribution of effect to a specific mechanism matters, the standalone components are the appropriate tools. For applied multi-axis studies where the entire blend is the intervention being studied, Super Shred is the appropriate compound. <\/p>\n<h2>Lagerung und Handhabung<\/h2>\n<p><strong>Bei Erhalt:<\/strong> Unmittelbar bei 2\u20138 \u00b0C k\u00fchlen. Die Ampulle wird in temperaturkontrollierter Verpackung versendet \u2014 umgehend in einen separaten K\u00fchlschrank \u00fcberf\u00fchren. <strong>Nicht einfrieren<\/strong> die Fl\u00fcssigkeit \u2014 Gefrier-Tau-Zyklen f\u00fchren zu Vitamin-B12-Abbau, ATP-Hydrolyse und potenziell Albuterol-Oxidation. Sch\u00fctzen Sie sie stets vor direktem Licht (B12 ist lichtempfindlich). Die klare, hellgelbe Farbe spiegelt Cyanocobalamin wider und ist normal; eine tiefere Farbverdunkelung oder das Auftreten von Partikeln deutet auf Abbau hin \u2014 solche Ampullen verwerfen. <strong>Handhabung der Ampulle:<\/strong> Super Shred is supplied as a sterile multi-dose vial. Use aseptic technique for each withdrawal: wipe the stopper with 70% isopropyl alcohol; use a fresh sterile needle and syringe per withdrawal. Do not over-pressurise the vial \u2014 air injection into a multi-dose vial is acceptable but should be modest. Swirl gently before each withdrawal to ensure uniform mixing of the five components. Once first-punctured, use within 60 days. Discard the vial if any cloudiness, particulates, colour deepening, or odour change appears. <\/p>\n<h2>H\u00e4ufig gestellte Fragen<\/h2>\n<h3>Ist Super Shred ein Peptid?<\/h3>\n<p>No. Super Shred is a multi-ingredient small-molecule studies-injectable blend \u2014 not a peptide. We stock it in our studies-peptide catalogue alongside <a href=\"https:\/\/medsbase.com\/de\/nad\/\">NAD\u207a<\/a> und <a href=\"https:\/\/medsbase.com\/de\/l-carnitine\/\">L-Carnitin<\/a> because it serves complementary mitochondrial \/ metabolic support applications and is supplied in the same injectable-vial format. The Spec Sequence row is marked &#8220;n\/a&#8221; for this reason and the Ingredient Breakdown table replaces the single-CAS-row format used for individual peptides. <\/p>\n<h3>Warum hei\u00dft die Mischung \u201cSuper Shred\u201d?<\/h3>\n<p>&#8220;Super Shred&#8221; is the supplier&#8217;s product designation reflecting the blend&#8217;s marketing positioning around fat-oxidation and metabolic support. The studies framing used here is broader than the marketing name suggests \u2014 fat-oxidation is one application but multi-axis adrenergic and mitochondrial are equally relevant uses. We retain the supplier name for cross-vendor traceability. <\/p>\n<h3>Was bedeutet \u201cMIC-Mischung\u201d und was sind die drei Komponenten?<\/h3>\n<p>MIC is the classical lipotropic studies mixture: <strong>M<\/strong>Ethionin (eine essentielle Aminos\u00e4ure und Methylgruppendonor), <strong>I<\/strong>Inositol (ein carbocyclischer Polyol-Cofaktor f\u00fcr die Second-Messenger-Phosphoinositid-Signal\u00fcbertragung) und <strong>C<\/strong>holine (a precursor for phosphatidylcholine biosynthesis and the lipid neurotransmitter acetylcholine). Together these three compounds support hepatic phospholipid biosynthesis and lipoprotein export \u2014 historically the basis for the &#8220;lipotropic&#8221; studies designation. The 100 mg\/mL combined dose places MIC in a moderate-supplementation range used in published studies protocols. <\/p>\n<h3>Warum ist Albuterol enthalten? Ist dies in meiner Rechtsprechung legal?<\/h3>\n<p>Albuterol (salbutamol) is a selective \u03b22-adrenergic agonist included in this blend for its established studies effects on adrenergic-receptor-mediated lipolysis and skeletal-muscle metabolism. <strong>Albuterol is a regulated drug in most jurisdictions<\/strong> and is on the WADA Prohibited List above defined urinary thresholds. Users handling this product are responsible for compliance with the regulatory framework in their jurisdiction. <\/p>\n<h3>Was bedeutet \u201ccompounded blend\u201d?<\/h3>\n<p>A compounded blend is a formulation that combines multiple individual active ingredients into a single pre-mixed solution at fixed ratios. Unlike a single-component product (like our <a href=\"https:\/\/medsbase.com\/de\/l-carnitine\/\">eigenst\u00e4ndiges L-Carnitin<\/a>), a compounded blend cannot be cleanly attributed to a single mechanism \u2014 the observed effects are the sum of all components acting together. Compounded blends are preferred when the entire combination is the studies intervention being studied; standalone components are preferred when single-mechanism attribution matters. <\/p>\n<h3>Wie unterscheidet sich dies von der Rekonstitution der lyophilisierten Peptide?<\/h3>\n<p>The lyophilized peptide products in this catalogue ship as dry powder and require reconstitution with bacteriostatic water before use. Super Shred is supplied as a pre-formulated sterile liquid \u2014 ready to use, no reconstitution needed. This simplifies protocol setup but limits shelf life after first vial puncture compared to the dry-lyophilized format. <\/p>\n<h3>Kann ich Super Shred einfrieren, um die Haltbarkeit zu verl\u00e4ngern?<\/h3>\n<p>Nein. Die Mischung enth\u00e4lt Komponenten, die durch Gefrier-Tau-Zyklen besch\u00e4digt werden \u2014 B12 (Cyanocobalamin) ist empfindlich gegen\u00fcber durch Einfrieren verursachten photolytischen Sch\u00e4den, ATP kann hydrolysiert werden und Albuterol kann oxidieren. K\u00fchl bei 2\u20138 \u00b0C lagern und innerhalb von 60 Tagen nach dem ersten Durchstechen verwenden. Die lyophilisierten Einzelkomponenten (L-Carnitin, NAD\u207a) k\u00f6nnen zur Langzeitlagerung eingefroren werden \u2014 die zusammengesetzte Fl\u00fcssigkeitsmischung jedoch nicht. <\/p>\n<h3>What administration routes are used in published studies?<\/h3>\n<p>Intramuscular and subcutaneous routes are the most common in published studies on multi-ingredient lipotropic and adrenergic-metabolic blends. Intravenous administration is less common because of the higher volume per dose. Users should determine the appropriate route from peer-reviewed literature specific to their protocol \u2014 and note that the regulatory framework for albuterol administration may further constrain the available routes in some jurisdictions. <\/p>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 20px 0 8px; border-radius: 4px; font-size: 14px;\"><strong>Why order compounds from MedsBase:<\/strong> Sterile pre-formulated liquid &amp; lyophilized peptides \u00b7 COA available on request \u00b7 Discreet temperature-controlled packaging \u00b7 Worldwide peptide courier \u00b7 <a href=\"https:\/\/medsbase.com\/de\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance<\/a> bei jeder Bestellung \u00b7 1.400+ verifiziert <a href=\"https:\/\/medsbase.com\/de\/reviews\/\">Kundenbewertungen<\/a><\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Companion Compounds<\/h2>\n<ul>\n<li><a href=\"\/de\/l-carnitine\/\"><strong>L-Carnitin (Levocarnitin)<\/strong><\/a> \u2014 Standalone L-Carnitine vials for dose-titration studies or alternative protocols<\/li>\n<li><a href=\"\/de\/b12-cyanocobalamin\/\"><strong>Vitamin B12 (Cyanocobalamin) Injektionsl\u00f6sung<\/strong><\/a> \u2014 Einzelne B12-Komponente f\u00fcr separate Dosierung<\/li>\n<li><a href=\"\/de\/5-amino-1mq\/\"><strong>5-Amino-1MQ<\/strong><\/a> \u2014 NNMT inhibitor for NAD-axis \/ metabolic support<\/li>\n<li><a href=\"\/de\/aod-9604\/\"><strong>AOD-9604<\/strong><\/a> \u2014 HGH-Fragment lipolytisches Peptid \u2014 orthogonaler Fettabbau-Mechanismus<\/li>\n<li><a href=\"\/de\/aicar-acadesine\/\"><strong>AICAR (Acadesin)<\/strong><\/a> \u2014 AMPK activator \u2014 exercise-mimetic studies<\/li>\n<li><a href=\"\/de\/bac-water\/\"><strong>BAC-Wasser (Bakteriostatisches Wasser)<\/strong><\/a> \u2014 Steriles 0,9% Benzylalkohol-Diluent f\u00fcr alle lyophilisierten Begleitampullen<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Multi-axis compounded studies-injectable blend (5 actives, not a peptide)<br \/>\n\u2705 10 mL steriles Fl\u00fcssigfl\u00e4schchen @ 553 mg\/mL Gesamtkonzentration<br \/>\n\u2705 L-Carnitin 400 + MIC 100 + ATP 50 + Albuterol 2 + B12 1 mg\/mL<br \/>\n\u2705 Vorgefertigt \u2014 keine Rekonstitution erforderlich<br \/>\n\u2705 Bei 2\u20138 \u00b0C k\u00fchlen; nicht einfrieren; 60-Tage-Fenster nach Anstich<\/p>\n<p><strong>Super Shred<\/strong> contains a compounded multi-ingredient studies blend.<\/p>","protected":false},"featured_media":71429,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5747,6476,6477,6478,6469,6474,6475,6473],"class_list":["post-71415","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-albuterol","product_tag-atp","product_tag-b12","product_tag-compounded-blend","product_tag-l-carnitine","product_tag-lipotropic","product_tag-mic","product_tag-super-shred","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product\/71415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/comments?post=71415"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/media\/71429"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/media?parent=71415"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product_brand?post=71415"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product_cat?post=71415"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product_tag?post=71415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}